ZNF33CP

Across TCGA pan-cancer cohorts, ZNF33CP RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of ZNF33CP’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where ZNF33CP RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF33CP is over-expressed in tumor, although a few such as THCA and LUAD show the opposite, repressed pattern.

KIRC, KIRP, and THCA are the cancer types where ZNF33CP tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF33CP RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	+0.167	<.001	8	view →
KIRP	Male	III,IV	+0.022	.032	2	view →
THCA	Male	All	−0.020	.032	2	view →
LUAD	Female	II,III,IV	−0.021	.034	1	view →
STAD	All	All	−0.020	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

ZNF33CP–KIRC

Open the KIRC breakdown →